Decline incidence in upper gastrointestinal bleeding in several recent years: data of the Japan claims database of 13 million accumulated patients

This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper gastrointestinal bleeding was evaluated in the Japan Medical Data Center claims database of 13,019,713 patients aged 20 to 74 years with traceabilit...

Full description

Saved in:
Bibliographic Details
Published inJournal of Clinical Biochemistry and Nutrition Vol. 68; no. 1; pp. 95 - 100
Main Authors Fujimoto, Shun, Tsuruoka, Nanae, Esaki, Motohiro, Takamori, Ayako, Sakata, Yasuhisa, Shimoda, Ryo, Akutagawa, Takashi, Node, Koichi, Anzai, Keizo, Sugisaki, Nobuyuki, Iwakiri, Ryuichi, Takagi, Kuniaki, Yamanouchi, Kohei, Fujimoto, Kazuma
Format Journal Article
LanguageEnglish
Published Japan SOCIETY FOR FREE RADICAL RESEARCH JAPAN 01.01.2021
Japan Science and Technology Agency
the Society for Free Radical Research Japan
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper gastrointestinal bleeding was evaluated in the Japan Medical Data Center claims database of 13,019,713 patients aged 20 to 74 years with traceability for 3 months from 2009 to 2014. The incidence was compared with peptic ulcers and gastroesophageal reflux disease. The prescription of medications was also evaluated. The incidence of bleeding was 0.137%, 0.121%, 0.113%, 0.106%, 0.099%, and 0.105% during 2009 to 2014 with a time-dependent decline (p<0.001). Peptic ulcers (>10 times higher than the incidence of bleeding) decreased with time (p<0.001), whereas gastroesophageal reflux disease increased (p = 0.006). Upper gastrointestinal bleeding was higher in male patients and older patients (60–74 years old) (p<0.001 respectively). The prescription rate of antithrombotic medications and proton pump inhibitors increased from 2009 to 2014 (p<0.001 respectively). The incidence of upper gastrointestinal bleeding decreased from 2009 to 2014 in this relatively large-scale real-world database in Japan, concomitant with the decrease in peptic ulcers. The decreased incidence might have been due to changes in the disease structure and therapeutic strategies over time.
AbstractList This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper gastrointestinal bleeding was evaluated in the Japan Medical Data Center claims database of 13,019,713 patients aged 20 to 74 years with traceability for 3 months from 2009 to 2014. The incidence was compared with peptic ulcers and gastroesophageal reflux disease. The prescription of medications was also evaluated. The incidence of bleeding was 0.137%, 0.121%, 0.113%, 0.106%, 0.099%, and 0.105% during 2009 to 2014 with a time-dependent decline ( 0.001). Peptic ulcers (>10 times higher than the incidence of bleeding) decreased with time ( 0.001), whereas gastroesophageal reflux disease increased (  = 0.006). Upper gastrointestinal bleeding was higher in male patients and older patients (60-74 years old) ( <0.001 respectively). The prescription rate of antithrombotic medications and proton pump inhibitors increased from 2009 to 2014 ( <0.001 respectively). The incidence of upper gastrointestinal bleeding decreased from 2009 to 2014 in this relatively large-scale real-world database in Japan, concomitant with the decrease in peptic ulcers. The decreased incidence might have been due to changes in the disease structure and therapeutic strategies over time.
This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper gastrointestinal bleeding was evaluated in the Japan Medical Data Center claims database of 13,019,713 patients aged 20 to 74 years with traceability for 3 months from 2009 to 2014. The incidence was compared with peptic ulcers and gastroesophageal reflux disease. The prescription of medications was also evaluated. The incidence of bleeding was 0.137%, 0.121%, 0.113%, 0.106%, 0.099%, and 0.105% during 2009 to 2014 with a time-dependent decline ( p< 0.001). Peptic ulcers (>10 times higher than the incidence of bleeding) decreased with time ( p< 0.001), whereas gastroesophageal reflux disease increased ( p  = 0.006). Upper gastrointestinal bleeding was higher in male patients and older patients (60–74 years old) ( p <0.001 respectively). The prescription rate of antithrombotic medications and proton pump inhibitors increased from 2009 to 2014 ( p <0.001 respectively). The incidence of upper gastrointestinal bleeding decreased from 2009 to 2014 in this relatively large-scale real-world database in Japan, concomitant with the decrease in peptic ulcers. The decreased incidence might have been due to changes in the disease structure and therapeutic strategies over time.
This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper gastrointestinal bleeding was evaluated in the Japan Medical Data Center claims database of 13,019,713 patients aged 20 to 74 years with traceability for 3 months from 2009 to 2014. The incidence was compared with peptic ulcers and gastroesophageal reflux disease. The prescription of medications was also evaluated. The incidence of bleeding was 0.137%, 0.121%, 0.113%, 0.106%, 0.099%, and 0.105% during 2009 to 2014 with a time-dependent decline (p<0.001). Peptic ulcers (>10 times higher than the incidence of bleeding) decreased with time (p<0.001), whereas gastroesophageal reflux disease increased (p = 0.006). Upper gastrointestinal bleeding was higher in male patients and older patients (60–74 years old) (p<0.001 respectively). The prescription rate of antithrombotic medications and proton pump inhibitors increased from 2009 to 2014 (p<0.001 respectively). The incidence of upper gastrointestinal bleeding decreased from 2009 to 2014 in this relatively large-scale real-world database in Japan, concomitant with the decrease in peptic ulcers. The decreased incidence might have been due to changes in the disease structure and therapeutic strategies over time.
This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper gastrointestinal bleeding was evaluated in the Japan Medical Data Center claims database of 13,019,713 patients aged 20 to 74 years with traceability for 3 months from 2009 to 2014. The incidence was compared with peptic ulcers and gastroesophageal reflux disease. The prescription of medications was also evaluated. The incidence of bleeding was 0.137%, 0.121%, 0.113%, 0.106%, 0.099%, and 0.105% during 2009 to 2014 with a time-dependent decline (p<0.001). Peptic ulcers (>10 times higher than the incidence of bleeding) decreased with time (p<0.001), whereas gastroesophageal reflux disease increased (p = 0.006). Upper gastrointestinal bleeding was higher in male patients and older patients (60–74 years old) (p<0.001 respectively). The prescription rate of antithrombotic medications and proton pump inhibitors increased from 2009 to 2014 (p<0.001 respectively). The incidence of upper gastrointestinal bleeding decreased from 2009 to 2014 in this relatively large-scale real-world database in Japan, concomitant with the decrease in peptic ulcers. The decreased incidence might have been due to changes in the disease structure and therapeutic strategies over time.
Author Sakata, Yasuhisa
Takagi, Kuniaki
Fujimoto, Kazuma
Akutagawa, Takashi
Sugisaki, Nobuyuki
Fujimoto, Shun
Node, Koichi
Tsuruoka, Nanae
Esaki, Motohiro
Shimoda, Ryo
Iwakiri, Ryuichi
Yamanouchi, Kohei
Anzai, Keizo
Takamori, Ayako
Author_xml – sequence: 1
  fullname: Fujimoto, Shun
  organization: Department of Internal Medicine, Faculty of Medicine, Saga University
– sequence: 2
  fullname: Tsuruoka, Nanae
  organization: Department of Internal Medicine, Faculty of Medicine, Saga University
– sequence: 3
  fullname: Esaki, Motohiro
  organization: Department of Internal Medicine, Faculty of Medicine, Saga University
– sequence: 4
  fullname: Takamori, Ayako
  organization: Division of Clinical Research Center, Saga University Hospital
– sequence: 5
  fullname: Sakata, Yasuhisa
  organization: Department of Internal Medicine, Faculty of Medicine, Saga University
– sequence: 6
  fullname: Shimoda, Ryo
  organization: Department of Internal Medicine, Faculty of Medicine, Saga University
– sequence: 7
  fullname: Akutagawa, Takashi
  organization: Department of Internal Medicine, Faculty of Medicine, Saga University
– sequence: 8
  fullname: Node, Koichi
  organization: Department of Internal Medicine, Faculty of Medicine, Saga University
– sequence: 9
  fullname: Anzai, Keizo
  organization: Department of Internal Medicine, Faculty of Medicine, Saga University
– sequence: 10
  fullname: Sugisaki, Nobuyuki
  organization: EA Pharma Co., Ltd
– sequence: 11
  fullname: Iwakiri, Ryuichi
  organization: Takeda Pharmaceutical Company, Ltd
– sequence: 12
  fullname: Takagi, Kuniaki
  organization: Divison of Gastroenterology, Faculty of Medicine, International University of Health and Welfare
– sequence: 13
  fullname: Yamanouchi, Kohei
  organization: Divison of Gastroenterology, Faculty of Medicine, International University of Health and Welfare
– sequence: 14
  fullname: Fujimoto, Kazuma
  organization: Divison of Gastroenterology, Faculty of Medicine, International University of Health and Welfare
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33536718$$D View this record in MEDLINE/PubMed
BookMark eNpdkU9v1DAQxS1URLeFE3dkiQtSlWLHjuPlUKkq5Z8qcYGzNbFnd71ynGAnlfo1-MQ4bFkBF48176enmXln5CQOEQl5ydml4Eq-3dsuXtas4o14QlZca1Y1TKsTsmJrXleMsfUpOct5z5hUjZLPyKkQjVAt1yvy8z3a4CNSH613GO3yo_M4YqJbyFMafJwwTz5CoF1AdD5uFyTjPabSS2gxTvQBIeV31MEEdNjQaYf0C4wQqQ3g-_xb6CDjInJBex-CHyIFa-d-DjChoyNMvljl5-TpBkLGF4_1nHz_cPvt5lN19_Xj55vru8oqLqeqY86h1lpxLcHpDqxcl06DXDT1Wqmudd2mabAGBgKctVJwzZ1zG6eAqVack6uD7zh3PbpljbKQGZPvIT2YAbz5V4l-Z7bDvWm1LIdcF4M3jwZp-DGXI5neZ4shQMRhzqaWWkklWi0K-vo_dD_Mqdx0oVrZqJbVi-HFgbJpyDnh5jgMZ2bJ2ixZm5qZknWhX_09_5H9E24Brg_APk-wxSMAafI24MFMacOX52B61OwOksEofgFBdMJv
CitedBy_id crossref_primary_10_1097_MD_0000000000037274
crossref_primary_10_3748_wjg_v29_i18_2717
crossref_primary_10_1002_jgh3_12666
crossref_primary_10_15829_1560_4071_2021_4635
crossref_primary_10_3164_jcbn_23_111
crossref_primary_10_3164_jcbn_23_82
Cites_doi 10.1111/hel.12597
10.3164/jcbn.19-66
10.3164/jcbn.20-51
10.1111/hel.12329
10.1053/j.gastro.2016.09.006
10.3164/jcbn.18-115
10.1159/000492492
10.1159/000490889
10.1007/s00535-019-01559-9
10.1111/hel.12575
10.1111/j.1523-5378.2007.00488.x
10.1111/j.1443-1661.2008.00825.x
10.1111/apt.12907
10.3164/jcbn.17-142
10.1371/journal.pone.0195164
10.1111/den.13577
10.1159/000498967
10.1007/s12072-019-09939-2
10.1136/gutjnl-2017-315131
10.1007/s00535-011-0429-3
10.7150/ijms.28877
10.1007/s00535-009-0047-5
10.2188/jea.JE20090066
10.1080/00365521.2019.1671487
10.3164/jcbn.20-37
10.1136/gutjnl-2015-311304
10.1007/s00228-006-0171-6
10.1111/hel.12495
10.5056/jnm18001
10.1111/j.1365-2036.2004.02220.x
10.1080/17474124.2017.1270205
10.1159/000484228
10.1007/s00535-018-1483-x
10.1159/000485653
10.1136/gutjnl-2019-319300
10.1111/j.1443-1661.2009.00898.x
10.2169/internalmedicine.3248-19
10.1136/gutjnl-2019-319954
10.1111/den.12639
10.1016/S0016-5107(00)70291-4
10.1136/gutjnl-2020-320705
10.3164/jcbn.17-78
10.1007/s00535-007-2157-2
10.1007/s00535-016-1227-8
10.1111/den.12316
10.1007/s00535-013-0839-5
10.2169/internalmedicine.8669-16
10.1007/s00535-005-1720-y
10.1007/s00535-016-1166-4
10.5604/16652681.1198800
10.1111/hepr.13417
10.1053/j.tvir.2012.07.006
ContentType Journal Article
Copyright 2021 JCBN
Copyright © 2021 JCBN.
2021. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2021 JCBN 2021
Copyright_xml – notice: 2021 JCBN
– notice: Copyright © 2021 JCBN.
– notice: 2021. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2021 JCBN 2021
DBID NPM
AAYXX
CITATION
7QL
7QP
7TK
7U9
C1K
H94
K9.
NAPCQ
7X8
5PM
DOI 10.3164/jcbn.20-153
DatabaseName PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
Nursing & Allied Health Premium
Virology and AIDS Abstracts
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList PubMed

Nursing & Allied Health Premium

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Diet & Clinical Nutrition
EISSN 1880-5086
EndPage 100
ExternalDocumentID 10_3164_jcbn_20_153
33536718
article_jcbn_68_1_68_20_153_article_char_en
Genre Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
.GJ
29K
2WC
5GY
ACGFO
ACPRK
ADBBV
ADRAZ
AENEX
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CS3
D-I
DIK
DU5
E3Z
F5P
GX1
HH5
HYE
JSF
JSH
KQ8
M48
O5R
O5S
OK1
P6G
PQEST
PQQKQ
RJT
RPM
RZJ
TKC
TR2
NPM
AAYXX
CITATION
7QL
7QP
7TK
7U9
C1K
H94
K9.
NAPCQ
7X8
5PM
ID FETCH-LOGICAL-c614t-b0dde8886184ad8bac49dde5e1352966b7dbf55e2a0a3adcc43181dddfd6a0673
IEDL.DBID RPM
ISSN 0912-0009
IngestDate Tue Apr 09 21:51:29 EDT 2024
Fri Aug 16 03:47:27 EDT 2024
Thu Oct 10 20:47:06 EDT 2024
Fri Aug 23 01:35:47 EDT 2024
Sat Sep 28 08:39:57 EDT 2024
Wed Apr 05 07:42:58 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords JMDC
peptic ulcer
gastroesophageal reflux disease
proton pump inhibitor
antithrombotic
Language English
License Copyright © 2021 JCBN.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c614t-b0dde8886184ad8bac49dde5e1352966b7dbf55e2a0a3adcc43181dddfd6a0673
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844659/
PMID 33536718
PQID 2474567029
PQPubID 1996339
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7844659
proquest_miscellaneous_2486463783
proquest_journals_2474567029
crossref_primary_10_3164_jcbn_20_153
pubmed_primary_33536718
jstage_primary_article_jcbn_68_1_68_20_153_article_char_en
PublicationCentury 2000
PublicationDate 2021-01-01
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Gifu
– name: Kyoto, Japan
PublicationTitle Journal of Clinical Biochemistry and Nutrition
PublicationTitleAlternate J. Clin. Biochem. Nutr.
PublicationYear 2021
Publisher SOCIETY FOR FREE RADICAL RESEARCH JAPAN
Japan Science and Technology Agency
the Society for Free Radical Research Japan
Publisher_xml – name: SOCIETY FOR FREE RADICAL RESEARCH JAPAN
– name: Japan Science and Technology Agency
– name: the Society for Free Radical Research Japan
References 24 Takara Y, Endo H, Nakano R, et al. Smoking and drinking did not increase the failure of therapeutic Helicobacter pylori eradication by vonoprazan, clarithromycin, and amoxicillin. Digestion 2019; 99: 172–178.
27 Li M, Oshima T, Horikawa T, et al. Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori. Helicobacter 2018; 23: e12495.
18 Sakamoto C, Sugano K, Ota S, et al. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol 2006; 62: 765–772.
51 Kinoshita Y, Ishimura N, Ishihara S. Advantages and disadvantages of long-term proton pump inhibitor use. J Neurogastroenterol Motil 2018; 24: 182–196.
28 Handa O, Naito Y, Osawa M, et al. Nutrients and probiotics: current trends in their use to eradicate Helicobacter pylori. J Clin Biochem Nutr 2020; 67: 26–28.
8 Araki T, Saad WE. Balloon-occluded retrograde transvenous obliteration of gastric varices from unconventional systemic veins in the absence of gastrorenal shunts. Tech Vasc Interv Radiol 2012; 15: 241–253.
12 Shimoda R, Iwakiri R, Sakata H, et al. Endoscopic hemostasis with metallic hemoclips for iatrogenic Mallory-Weiss tear caused by endoscopic examination. Dig Endosc 2009; 21: 20–23.
23 Suzuki S, Gotoda T, Kusano C, et al. Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan. Gut 2020; 69: 1019–1026.
34 Kakiuchi T, Matsuo M, Endo H, et al. A Helicobacter pylori screening and treatment program to eliminate gastric cancer among junior high school students in Saga Prefecture: a preliminary report. J Gastroenterol 2019; 54: 699–707.
22 Suzuki H, Mori H. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. J Gastroenterol 2018; 53: 354–361.
32 Fujimoto Y, Furusyo N, Toyoda K, Takeoka H, Sawayama Y, Hayashi J. Intrafamilial transmission of Helicobacter pylori among the population of endemic areas in Japan. Helicobacter 2007; 12: 170–176.
46 Yamaguchi M, Iwakiri R, Yamaguchi K, et al. Bleeding and stenosis caused by reflux esophagitis was not common in emergency endoscopic examinations: a retrospective patient chart review at a single institution in Japan. J Gastroenterol 2008; 43: 265–269.
49 Kinoshita Y, Adachi K, Hongo M, Haruma K. Systematic review of the epidemiology of gastroesophageal reflux disease in Japan. J Gastroenterol 2011; 46: 1092–1103.
19 Nakamura S, Watanabe T, Shimada S, et al. Does discontinuation of antithrombotics affect the diagnostic yield of small bowel capsule endoscopy in patients demonstrating obscure gastrointestinal bleeding? J Clin Biochem Nutr 2018; 63: 149–153.
26 Furuta T, Yamade M, Kagami T, et al. Influence of clarithromycin on the bactericidal effect of amoxicillin in patients infected with clarithromycin-resistant strains of H. pylori. Gut 2020. DOI: 10.1136/gutjnl-2020-320705.
7 Tsuruoka N, Iwakiri R, Sakata Y, et al. Questionnaire-based survey on gastrointestinal bleeding and management of antithrombotic agents during endoscopy among Asian countries. Digestion 2018; 97: 97–106.
17 Yamaguchi D, Sakata Y, Tsuruoka N, et al. Characteristics of patients with non-variceal upper gastrointestinal bleeding taking antithrombotic agents. Dig Endosc 2015; 27: 30–36.
13 Sugisaki N, Iwakiri R, Tsuruoka N, et al. A case-control study of the risk of upper gastrointestinal mucosal injuries in patients prescribed concurrent NSAIDs and antithrombotic drugs based on data from the Japanese national claims database of 13 million accumulated patients. J Gastroenterol 2018; 53: 1253–1260.
15 Yokoyama S, Tanaka Y, Nakagita K, Hosomi K, Takada M. Bleeding risk of warfarin and direct oral anticoagulants in younger population: a historical cohort study using a Japanese claims database. Int J Med Sci 2018; 15: 1686–1693.
40 Wakatsuki T, Obara K, Irisawa A, et al. Analysis of prognostic factors in patients with gastric varices after endoscopic treatment. Dig Endosc 2009; 21: 232–238.
42 Tanaka J, Akita T, Ko K, Miura Y, Satake M; Epidemiological Research Group on Viral Hepatitis and its Long-term Course, Ministry of Health, Labour and Welfare of Japan. Countermeasures against viral hepatitis B and C in Japan: an epidemiological point of view. Hepatol Res 2019; 49: 990–1002.
47 Fujimoto K. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther 2004; 20 Suppl 8: 5–8.
5 Jono F, Iida H, Fujita K, et al. Comparison of computed tomography findings with clinical risks factors for endoscopic therapy in upper gastrointestinal bleeding cases. J Clin Biochem Nutr 2019; 65: 138–145.
30 Mukai R, Handa O, Suyama Y, Majima A, Naito Y. Effectiveness of including probiotics to Helicobacter pylori eradication therapies. J Clin Biochem Nutr 2020; 67: 102–104.
37 Iwakiri R, Higuchi K, Kato M, et al. Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin. Aliment Pharmacol Ther 2014; 40: 780–795.
10 Toshikuni N, Takuma Y, Tsutsumi M. Management of gastroesophageal varices in cirrhotic patients: current status and future directions. Ann Hepatol 2016; 15: 314–325.
2 Satoh K, Yoshino J, Akamatsu T, et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol 2016; 51: 177–194.
31 Mabe K, Kikuchi S, Okuda M, Takamasa M, Kato M, Asaka M. Diagnostic accuracy of urine Helicobacter pylori antibody test in junior and senior high school students in Japan. Helicobacter 2017; 22. DOI: 10.1111/hel.12329.
4 Chan FKL, Goh KL, Reddy N, et al. Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines. Gut 2018; 67: 405–417.
11 Ootani H, Iwakiri R, Shimoda R, et al. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan. J Gastroenterol 2006; 41: 41–46.
36 Uemura N, Sugano K, Hiraishi H, et al.; MAGIC Study Group. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. J Gastroenterol 2014; 49: 814–824.
53 Sakata Y, Tsuruoka N, Takedomi H, et al. A study on the status of proton pump inhibitor prescriptions using diagnosis procedure combination data in Japan. Digestion 2020; 101: 308–315.
29 Murakami K, Sakurai Y, Shiino M, Funao N, Nishimura A, Asaka M. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. Gut 2016; 65: 1439–1446.
21 Okuda M, Lin Y, Wang C, Kakiuchi T, Kikuchi S. Metronidazole for Helicobacter pylori eradication therapy among children and adolescents in Japan: overcoming controversies and concerns. Helicobacter 2019; 24: e12575.
39 Robertson M, Ng J, Abu Shawish W, et al. Risk stratification in acute variceal bleeding: comparison of the AIMS65 score to established upper gastrointestinal bleeding and liver disease severity risk stratification scoring systems in predicting mortality and rebleeding. Dig Endosc 2019. DOI: 10.1111/den.13577.
16 Chang CH, Sakaguchi M, Weil J, Verstraeten T. The incidence of medically-attended notovirus gastroenteritis in Japan: modelling using a medical care insurance claims database. PLoS One 2018; 13: e0195164.
33 Tanaka Y, Sakata Y, Hara M, et al. Risk factors for Helicobacter pylori infection and endoscopic reflux esophagitis in healthy young Japanese volunteers. Intern Med 2017; 56: 2979–2983.
9 Iwamoto J, Murakami M, Monma T, et al. Current status of prevention of drug-induced gastroduodenal ulcer in real practice: a cross-sectional study. J Clin Biochem Nutr 2020; 66: 158–162.
41 Iwakiri R, Koyama T, Hirano M, et al. Endoscopic injection sclerotherapy for esophageal varices prolonged survival of patients with hepatocellular carcinoma complicating liver cirrhosis. Gastrointest Endosc 2000; 51: 569–572.
38 Szeto CC, Sugano K, Wang JG, et al. Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations. Gut 2020; 69: 617–629.
6 Matsuura S, Sakata Y, Tsuruoka N, et al. Outcomes of patients undergoing endoscopic hemostasis for the upper gastrointestinal bleeding were not influenced by the timing of hospital emergency visits: a situation prevailing in Japan. Digestion 2018; 97: 260–266.
20 Kato M, Ota H, Okuda M, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition. Helicobacter 2019; 24: e12597.
52 Takagi T, Naito Y, Inoue R, et al. The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study. J Clin Biochem Nutr 2018; 62: 100–105.
14 Kimura S, Sato T, Ikeda S, Noda M, Nakayama T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol 2010; 20: 413–419.
25 Harada A, Kurahara K, Moriyama T, et al. Risk factors for reflux esophagitis after eradication of Helicobacter pylori. Scand J Gastroenterol 2019; 54: 1183–1188.
45 Ide T, Koga H, Nakano M, et al. Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study. Hepatol Int 2019; 13: 293–301.
43 Isoda H, Oeda S, Takamori A, et al. Generation gap for screening and treatment of hepatitis C virus in Saga prefecture, Japan: an administrative database study of 35,625 subjects. Intern Med 2020; 59: 169–174.
44 Hayes CN, Imamura M, Chayama
44
45
46
47
48
49
50
51
52
53
10
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
References_xml – ident: 20
  doi: 10.1111/hel.12597
– ident: 9
  doi: 10.3164/jcbn.19-66
– ident: 28
  doi: 10.3164/jcbn.20-51
– ident: 31
  doi: 10.1111/hel.12329
– ident: 35
  doi: 10.1053/j.gastro.2016.09.006
– ident: 5
  doi: 10.3164/jcbn.18-115
– ident: 3
  doi: 10.1159/000492492
– ident: 24
  doi: 10.1159/000490889
– ident: 34
  doi: 10.1007/s00535-019-01559-9
– ident: 21
  doi: 10.1111/hel.12575
– ident: 32
  doi: 10.1111/j.1523-5378.2007.00488.x
– ident: 12
  doi: 10.1111/j.1443-1661.2008.00825.x
– ident: 37
  doi: 10.1111/apt.12907
– ident: 19
  doi: 10.3164/jcbn.17-142
– ident: 16
  doi: 10.1371/journal.pone.0195164
– ident: 39
  doi: 10.1111/den.13577
– ident: 53
  doi: 10.1159/000498967
– ident: 22
– ident: 45
  doi: 10.1007/s12072-019-09939-2
– ident: 4
  doi: 10.1136/gutjnl-2017-315131
– ident: 49
  doi: 10.1007/s00535-011-0429-3
– ident: 15
  doi: 10.7150/ijms.28877
– ident: 48
  doi: 10.1007/s00535-009-0047-5
– ident: 14
  doi: 10.2188/jea.JE20090066
– ident: 25
  doi: 10.1080/00365521.2019.1671487
– ident: 30
  doi: 10.3164/jcbn.20-37
– ident: 29
  doi: 10.1136/gutjnl-2015-311304
– ident: 18
  doi: 10.1007/s00228-006-0171-6
– ident: 27
  doi: 10.1111/hel.12495
– ident: 51
  doi: 10.5056/jnm18001
– ident: 47
  doi: 10.1111/j.1365-2036.2004.02220.x
– ident: 44
  doi: 10.1080/17474124.2017.1270205
– ident: 7
  doi: 10.1159/000484228
– ident: 13
  doi: 10.1007/s00535-018-1483-x
– ident: 6
  doi: 10.1159/000485653
– ident: 38
  doi: 10.1136/gutjnl-2019-319300
– ident: 40
  doi: 10.1111/j.1443-1661.2009.00898.x
– ident: 43
  doi: 10.2169/internalmedicine.3248-19
– ident: 23
  doi: 10.1136/gutjnl-2019-319954
– ident: 1
  doi: 10.1111/den.12639
– ident: 41
  doi: 10.1016/S0016-5107(00)70291-4
– ident: 26
  doi: 10.1136/gutjnl-2020-320705
– ident: 52
  doi: 10.3164/jcbn.17-78
– ident: 46
  doi: 10.1007/s00535-007-2157-2
– ident: 50
  doi: 10.1007/s00535-016-1227-8
– ident: 17
  doi: 10.1111/den.12316
– ident: 36
  doi: 10.1007/s00535-013-0839-5
– ident: 33
  doi: 10.2169/internalmedicine.8669-16
– ident: 11
  doi: 10.1007/s00535-005-1720-y
– ident: 2
  doi: 10.1007/s00535-016-1166-4
– ident: 10
  doi: 10.5604/16652681.1198800
– ident: 42
  doi: 10.1111/hepr.13417
– ident: 8
  doi: 10.1053/j.tvir.2012.07.006
SSID ssj0046564
Score 2.335035
Snippet This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper...
SourceID pubmedcentral
proquest
crossref
pubmed
jstage
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 95
SubjectTerms antithrombotic
Bleeding
Data centers
Evaluation
Gastroesophageal reflux
gastroesophageal reflux disease
JMDC
Original
peptic ulcer
Peptic ulcers
proton pump inhibitor
Proton pump inhibitors
Time dependence
Ulcers
SummonAdditionalLinks – databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9NADLfGQIgXBOMrMJCRJt4Cbe5ySSYhhBjTNIk9UWlv0X1unbq0NKnE_g3-Yux8iU5746WKare5xPbZvvP9DHAgQ9A65CGW2ulYClmwzWWxNqRBIaUIwLZVvmfqZCZPz9PzHRiacfYvsL4zteN-UrP14uPvXzdfyOA_txmnkp-urGEk05iM9x7cTySl6FzDJ8ftBMYEa3GkCq5DoKiiO6h3-8dbrunBFUVnF_6uwPN2_eQ_Dun4CTzuI0n82on-Kez4ag-io7lv8AP2cJ8LPBvQ9vfg4Y9-H_0Z_DnyfCTSI6-0t11F6Qo3q5Vf44Wum_WSYSTI-vkOZtF5OGYhP8qLWEjzJI0Kb8hO6kPkMlNcBqRgEk_J-1ZoF3p-XbcE9pNMnArkFkc0FNTWbq65b5h32AO71s9hdvz957eTuO_OEFty6U1sJjQzUv7MHWO0y422sqBvUj8VvJerTOZMSFOf6IkW2llLoQoFx84FpzS3x3kBu9Wy8q8AtQxC-cw7J-m_8lybwmU5TQ4yJV2aJBEcDIIpVx0IR0nJC8uvZPmVCWUyqYjgsBPayNRbX8ek8nLKHx3zSOPTbTRFRLA_CLoctLBMZEYBZjZJigjej2QyQN5V0ZVfbpgnV1IJGm8ELzu9GO8vRCoUef8Isi2NGRkY3HubUs0vW5DvLGcou-L1_zzTG3iUcAlOu2K0D7vNeuPfUgzVmHetffwFUuciPA
  priority: 102
  providerName: Scholars Portal
Title Decline incidence in upper gastrointestinal bleeding in several recent years: data of the Japan claims database of 13 million accumulated patients
URI https://www.jstage.jst.go.jp/article/jcbn/68/1/68_20-153/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/33536718
https://www.proquest.com/docview/2474567029
https://search.proquest.com/docview/2486463783
https://pubmed.ncbi.nlm.nih.gov/PMC7844659
Volume 68
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Clinical Biochemistry and Nutrition, 2021, Vol.68(1), pp.95-100
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB7iUEIupU1fatOyhdCbYlu7q13lVpKGkOLQQgO5iX0pdbBlY8mH_I384s7oRVJ66mURnpG1MDM7M7uz3wAciaIwptBFLIw3seAiI5tTsbGoQYXECMA1Vb5X6cW1uLyRNzsg-7swTdG-s_PjcrE8Lue_m9rK9dKN-zqx8Y_ZqdIE85WNRzBCBe1T9Hb5JfyvBjMqo5oDjCDaS3kc04LxnbMEeRqjle_DHueSp4q6fTzySM_uMCi7Df-KN_8um3zkh85fwPMugGRf24m-hJ1QHkB0Ng81-8I6lM8Fu-pB9g9gb9Ydn7-Ch7NANyEDow32ppkoPrHteh027NZU9WZF6BFo9PQFu2gdG7Gg-6S9K4bLI86K3aN5VCeMqkvZqmAYQ7JLdLolcwszX1YNgdwjEaecUWcjnAozzm2X1C4seNbhuVav4fr826_Ti7hryhA79OR1bCe4IGLaTI1ijNfWOJHhLzJMOR3hplZ5W0gZEjMx3HjnMELBmNj7wqeGuuK8gd1yVYZ3wIwoeBpU8F7gf2ltbOaVxjVBSFShSRLBUS-YfN1ib-SYs5AocxJlnmACI3kEJ63QBqZOV1qmVOdTGlrmgUaX2nBliOCwF3TeWW-VJ0JhXKkmSRbB54GMdkeHKaYMqy3x6FSkHOcbwdtWL4bv95oVgXqiMQMDYXo_paCqN9jenWq__-83P8B-QmU3zS7RIezWm234iHFTbT_B6PtPjeNM0Ig28wfSyB7y
link.rule.ids 230,315,730,783,787,888,2228,24330,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VgkovPEppDQUWqeLmxPGuX72hliqUJuLQot6sfbmkJE4U2wf4GfxiZvxSW3GBS2RlJrFX_uaxu7PfAByKLJMyizNXSCNdwUVCNhe5UiGCsgAzAF1X-U7D8aU4uwquNiDozsLURftazQb5fDHIZ9_r2srVQg-7OrHh18lxFBPNVzJ8AA_RXj3RTdIbB0wMYDVrVEJVB5hDNMfyOE4MhjdaEempi3a-DVucBzyMqN_HrZj06AbTsmv7t4zzfuHkrUh0-hS-dWNoClB-DKpSDfSve_SO_zzIZ_CkzU3Zx0b8HDZsvgPOycyW7ANrCUTnbNrx9-_A1qTdmX8Bv08sHbK0jNbu6z6leMWq1cqu2bUsyvWSiCnQn9Ad1LyJmaSCkZmWxRh6Xhwu-4mWVxwxKlxly4xhesrOMJ7nTM_lbFHUAoq8JBxxRk2T8FGY1LpaUCcya1hLFVvswuXpp4vjsdv2e3A1Jgmlqzz0tTgjpx400sRKapHgN4EdcdodDlVkVBYE1pee5NJojckPptvGZCaU1HDnJWzmy9zuA5Mi46GNrDEC_yuOpUpMFKO7EQGi0_MdOOzeeLpqaD1SnA4RRlLCSOrj3CjgDhw1aOiV2jfUKIVxOqKPRrmX0Xk5dDoOHHQISlvHUKS-iDBljTw_ceB9L0aTpn0amdtlRTpxKEKOz-vAXgO4_v4dZB2I7kCxVyC68LsSBFhNG94C6tV___IdPB5fTM7T88_TL69h26fqnnox6gA2y3Vl32B6Vqq3tTH-Ad58PyQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB5BQVEvBcqjhgKLVHFzHt71qzfUEJVCox6oVHGx9uWSkjhWbB_gZ_CLmfFLacWpl8jKTmKvPI9vdme_ATgSaSplGqWukEa6gouYbC50pUINSn1EALqu8p0Hp5fi7Mq_2mr1VRfta7UYZsvVMFv8rGsr85UedXVio4vzkzAimq94lJt09BAeoc2Ogy5Rb5wwsYDVzFExVR4gjmiO5nFMDkY3WhHxqYu2vgsDzn0ehNTzYysuPb5BaHZt_4c67xZPbkWj2RP40c2jKUL5NaxKNdR_7lA83muiT2GvxajsUyPyDB7YbB-c6cKW7CNriUSXbN7x-O_D4LzdoX8Of6eWDltaRmv4db9SvGJVntsNu5ZFuVkTQQX6FbqDWjaxk0QwQtPyGEMPjFNmv9ECi2NGBaxsnTKEqewM43rG9FIuVkU9QBGYBiecUfMkfBQmta5W1JHMGtZSxhYv4HL2-fvJqdv2fXA1goXSVWP0uZiZUy8aaSIltYjxG99OOO0SByo0KvV968mx5NJojSAIYbcxqQkkNd55CTvZOrMHwKRIeWBDa4zA_4oiqWITRuh2hI9aOvYcOOreepI39B4JpkWkJwnpSeJhjuRzB44bjeiF2rfUCAVRMqGPRrgfo3Nz6HwcOOy0KGkdRJF4IkToGo692IEP_TCaNu3XyMyuK5KJAhFwfF4HXjVK19-_U1sHwlvq2AsQbfjtEVSymj68VarX9_7lexhcTGfJty_zr29g16Min3pN6hB2yk1l3yJKK9W72h7_AZ-jQaQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Decline+incidence+in+upper+gastrointestinal+bleeding+in+several+recent+years%3A+data+of+the+Japan+claims+database+of+13+million+accumulated+patients&rft.jtitle=Journal+of+Clinical+Biochemistry+and+Nutrition&rft.au=Fujimoto%2C+Shun&rft.au=Tsuruoka%2C+Nanae&rft.au=Esaki%2C+Motohiro&rft.au=Takamori%2C+Ayako&rft.date=2021-01-01&rft.pub=SOCIETY+FOR+FREE+RADICAL+RESEARCH+JAPAN&rft.issn=0912-0009&rft.eissn=1880-5086&rft.volume=68&rft.issue=1&rft.spage=95&rft.epage=100&rft_id=info:doi/10.3164%2Fjcbn.20-153&rft.externalDocID=article_jcbn_68_1_68_20_153_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0912-0009&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0912-0009&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0912-0009&client=summon